Welcome to our dedicated page for CORPAY SEC filings (Ticker: CPAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CORPAY's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CORPAY's regulatory disclosures and financial reporting.
Corpay, Inc. CEO and Chairman Ronald Clarke reported several equity-related transactions in Corpay common stock. On February 14, 2026, he received a grant or award of 6,630 shares of common stock at a stated price of $0.00 per share, increasing his direct holdings.
On the same date, he had three separate tax-withholding dispositions in connection with equity vesting: 2,920 shares, 3,215 shares, and 2,953 shares, each priced at $337.12 per share, used to satisfy tax liabilities incident to vesting under Rule 16b-3.
Corpay, Inc. director Jeffrey Steven Sloan reported an open-market sale of 3,600 shares of Common Stock. The transaction took place at an average price of $343.6154 per share. After this sale, Sloan’s directly held ownership stands at 12,474 shares of Corpay common stock.
Corpay, Inc. director Hala G. Moddelmog reported a tax-related share disposition. On February 14, 2026, 216 shares of common stock were withheld at $337.12 per share to cover tax liabilities tied to vesting under Rule 16b-3. After this withholding transaction, Moddelmog directly owns 7,614 shares of Corpay common stock.
Corpay, Inc. director Richard Macchia reported a tax-related share disposition. On the reported date, 216 shares of common stock were withheld at a price of $337.12 per share to cover tax liabilities tied to vesting of equity awarded under Rule 16b-3. After this tax-withholding disposition, Macchia’s directly owned holdings total 12,795 shares of Corpay common stock.
Corpay, Inc. director Archie L. Jones Jr. reported a small tax-related share disposition. On the transaction date, 216 shares of common stock were withheld at $337.12 per share to cover tax liabilities tied to vesting equity. After this withholding, he directly owns 3,944 common shares.
CORPAY, INC. director Rahul Gupta reported a Form 4 showing a tax-related share disposition. On the reported date, 256 shares of common stock were withheld at a price of $337.12 per share to cover tax obligations tied to vesting under Rule 16b-3. After this transaction, Gupta directly owned 2,713 common shares.
Corpay, Inc. director Annabelle G. Bexiga reported a small share disposition related to equity compensation taxes. On the transaction date, 175 shares of common stock were withheld at $337.12 per share to satisfy a tax liability upon vesting of a stock-based award. After this tax-withholding disposition, she directly owned 3,440 shares of Corpay common stock.
Corpay, Inc. director Gerald C. Throop reported a tax-related share disposition. On February 14, 2026, 436 shares of Corpay common stock were disposed of at $337.12 per share to satisfy tax withholding obligations upon vesting of an equity award. This was a tax-withholding transaction under Rule 16b-3, not an open-market trade. After this event, Throop directly held 1,549 Corpay common shares.
Corpay has a notice under Rule 144 indicating that a holder plans to sell 3,600 shares of its common stock through Goldman Sachs & Co. LLC on the NYSE, with an approximate sale date of 02/17/2026 and an aggregate market value of about 1,233,036.
The shares were originally acquired as compensation in the form of restricted stock units granted by the issuer between 2018 and 2020. Common shares outstanding were 69,958,056 as of the information provided, which is a baseline figure, not the amount being sold.
Orbis Investment Management Limited and related advisers filed an amended Schedule 13G reporting passive ownership of Corpay, Inc. common stock. The reporting persons together beneficially own 4,987,968 shares, representing 7.1% of the common stock as of 12/31/2025.
Orbis Investment Management Limited reports sole voting and dispositive power over 4,710,167 shares, Allan Gray Australia Pty Ltd over 3,317 shares, and Orbis Investment Management (U.S.), L.P. over 274,484 shares. The filers certify the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Corpay.